(Q34553354)

3 August 2017

1 reference

title

Ofloxacin clinical pharmacokinetics (English)

1 reference

3 August 2017

1 reference

K. C. Lamp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1559306

8 October 2022

E. M. Bailey

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1559306

8 October 2022

M. J. Rybak

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1559306

8 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1559306

8 October 2022

publication date

1 January 1992

1 reference

Clinical Pharmacokinetics

3 August 2017

1 reference

3 August 2017

22

1 reference

3 August 2017

32-46

1 reference

3 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-199222010-00004

3 August 2017

0 references

cites work

Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline

1 reference

12 December 2020

Penetration of ciprofloxacin and ofloxacin into human allograft pancreatic juice

1 reference

12 December 2020

Ofloxacin in human aqueous humour and lens

1 reference

12 December 2020

Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state.

1 reference

12 December 2020

Penetration of ofloxacin into bronchial secretions

1 reference

12 December 2020

Clinical efficacy of ofloxacin in lower respiratory tract infections. A multicentre study

1 reference

12 December 2020

Tissue penetration of the new quinolones in humans

1 reference

12 December 2020

Inhibition of drug metabolism by quinolone antibiotics.

1 reference

12 December 2020

The comparative pharmacokinetics of five quinolones

1 reference

12 December 2020

New synthetic quinolone antibacterial agents and serum concentration of theophylline

1 reference

12 December 2020

Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline

1 reference

12 December 2020

Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue

1 reference

12 December 2020

Bacterial resistance to quinolones: mechanisms and clinical importance.

1 reference

12 December 2020

Norfloxacin disposition after sequentially increasing oral doses

1 reference

12 December 2020

Drug-drug interactions affecting fluoroquinolones

1 reference

12 December 2020

Diffusion of ofloxacin into the cerebrospinal fluid in patients with bacterial meningitis

1 reference

12 December 2020

Structure-activity relationships of the fluoroquinolones

1 reference

12 December 2020

Concentrations of ofloxacin in human bone and in cartilage

1 reference

12 December 2020

1 reference

12 December 2020

Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Efficacy of ofloxacin in experimental Staphylococcus aureus endocarditis

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses

1 reference

12 December 2020

Comparative activity of ofloxacin and seven other antimicrobials against urea-splitting microorganisms.

1 reference

12 December 2020

Further methodological improvement in antibiotic bone concentration measurements: penetration of ofloxacin into bone and cartilage

1 reference

12 December 2020

Pharmacokinetics and tissue penetration of enoxacin

1 reference

12 December 2020

In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Diffusion of ofloxacin into human lung tissue

1 reference

12 December 2020

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

1 reference

12 December 2020

Pharmacokinetics of ofloxacin. An overview

1 reference

12 December 2020

The pharmacokinetics of ofloxacin in healthy adult male volunteers

1 reference

12 December 2020

1 reference

12 December 2020

Enoxacin--a potent inhibitor of theophylline metabolism.

1 reference

12 December 2020

Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orally

1 reference

12 December 2020

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

1 reference

12 December 2020

Effect of norfloxacin on theophylline pharmacokinetics at steady state

1 reference

12 December 2020

Pharmacokinetics of ofloxacin and theophylline alone and in combination

1 reference

12 December 2020

Ofloxacin versus parenteral therapy for chronic osteomyelitis

1 reference

12 December 2020

Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects

1 reference

12 December 2020

A simple isocratic high-pressure liquid chromatographic assay of quinolones in serum.

1 reference

12 December 2020

Antibacterial activity of ofloxacin and its mode of action

1 reference

12 December 2020

The influence of quinolone derivatives on theophylline clearance

1 reference

12 December 2020

Penetration of ofloxacin from blood to sputum

1 reference

12 December 2020

Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers

1 reference

12 December 2020

Enoxacin decreases the clearance of theophylline in man.

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

1 reference

12 December 2020

Pharmacokinetics of enoxacin and its penetration into bronchial secretions and lung tissue.

1 reference

12 December 2020

Study of the cerebrospinal fluid penetrability of ofloxacin.

1 reference

12 December 2020

Effect of renal impairment on distribution of ofloxacin

1 reference

12 December 2020

Ofloxacin pharmacokinetics in renal failure

1 reference

12 December 2020

Ofloxacin penetration into bile and pancreatic juice

1 reference

12 December 2020

The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Absence of interaction between ofloxacin and phenprocoumon

1 reference

12 December 2020

Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green

1 reference

12 December 2020

Clinical pharmacokinetics of the newer antibacterial 4-quinolones

1 reference

12 December 2020

A preliminary report on the pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in patients with chronic renal failure

1 reference

12 December 2020

Ofloxacin and warfarin

1 reference

12 December 2020

Plasmid-mediated 4-quinolone resistance: a real or apparent absence?

1 reference

12 December 2020

Development of resistance to ofloxacin

1 reference

12 December 2020

Bactericidal mechanisms of ofloxacin.

1 reference

12 December 2020

Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent

1 reference

12 December 2020

Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers

1 reference

12 December 2020

The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure

1 reference

12 December 2020

Pharmacokinetics of ofloxacin in patients on haemodialysis treatment

1 reference

12 December 2020

Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum

1 reference

12 December 2020

Biliary tract excretion of ofloxacin in man.

1 reference

12 December 2020

Pharmacokinetics of ofloxacin in healthy subjects and patients with impaired renal function

1 reference

12 December 2020

In vitro antimicrobial activity and susceptibility testing of ofloxacin. Current status.

1 reference

12 December 2020

Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates

1 reference

12 December 2020

Effect of ferrous sulfate and multivitamins with zinc on absorption of ciprofloxacin in normal volunteers

1 reference

12 December 2020

Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of norfloxacin

1 reference

12 December 2020

The use of quinolones in respiratory tract infections

1 reference

12 December 2020

Single and multiple dose pharmacokinetics of ciprofloxacin

1 reference

12 December 2020

Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method

1 reference

12 December 2020

Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans

1 reference

12 December 2020

Bronchial penetration of ofloxacin after single and multiple oral dosage

1 reference

12 December 2020

Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin

1 reference

12 December 2020

Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis

1 reference

12 December 2020

Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes

1 reference

12 December 2020

Synthesis and antibacterial activities of optically active ofloxacin

1 reference

12 December 2020

Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin.

1 reference

12 December 2020

A double-blind randomized study comparing ofloxacin and amoxicillin in treating infective episodes in bronchiectasis

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ofloxacin in serum, saliva, and skin blister fluid of healthy volunteers

1 reference

12 December 2020

The comparative in-vitro activity of ofloxacin

1 reference

12 December 2020

Pharmacokinetics of ofloxacin after parenteral and oral administration

1 reference

12 December 2020

Diffusion of ciprofloxacin into prostatic fluid

1 reference

12 December 2020

Pharmacokinetics of ofloxacin after single and multiple intravenous infusions in healthy subjects

1 reference

12 December 2020

In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients

1 reference

12 December 2020

Interaction between quinolones and caffeine

1 reference

12 December 2020

Sucralfate reduces the gastrointestinal absorption of norfloxacin

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of ofloxacin

1 reference

12 December 2020

Comparative pharmacokinetics of theophylline following two fluoroquinolones co-administration

1 reference

12 December 2020

Comparative activity of ofloxacin with reference to bacterial strains isolated in in-patients and out-patients.

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.

1 reference

12 December 2020

Ofloxacin penetration into cerebrospinal fluid

1 reference

12 December 2020

10.2165/00003088-199222010-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference